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Purpose: To describe and analyze the diagnostic performance of
uterine virtual navigation with three-dimensional (3D) ul-
trasonography (US) for the assessment of the depth of
myometrial infiltration by endometrial cancer.
Materials and
Methods:
Institutional review board approval was obtained; patients
gave oral informed consent. Women with endometrial
cancer were evaluated by using 3D US prior to surgical
staging. A 3D volume of the whole uterus was obtained and
analyzed by using software. Virtual navigation through
three orthogonal planes was performed to identify the
shortest myometrial tumor-free distance to serosa (TDS)
by analyzing the lateral, anterior, posterior, and fundal
portions of the myometrium. Myometrial infiltration was
also assessed by subjective impression of an examiner.
Histologic findings of myometrial infiltration and TDS mea-
sured by a pathologist were used as the reference stan-
dard. A receiver operating characteristic curve was plot-
ted to identify the best cutoff for TDS for identifying myo-
metrial infiltration of 50% or more.
Results: Ninety-six women (mean age, 61.8 years; range, 31–86
years) with endometrial cancer were included in the study.
At histologic analysis, myometrial invasion was found to be
less than 50% in 69 (72%) cases and 50% or more in 27
(28%) cases. TDS measured with US was positively corre-
lated with histologically measured TDS (r  0.649; 95%
confidence interval: 0.52, 0.76). The best cutoff for US-
measured TDS was 9.0 mm (sensitivity, 100%; specificity,
61%; negative predictive value, 100%; positive predictive
value, 50%). Subjective impression had a sensitivity of
92.6%, a specificity of 82.3%, a negative predictive value
of 96.6%, and a positive predictive value of 67.7%.
Conclusion: Uterine virtual navigation with 3D US is a reliable method
for the assessment of myometrial infiltration in patients
with endometrial cancer.
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Endometrial carcinoma is the mostfrequent gynecologic malignancy(1). Since 1988, the International
Federation of Gynecology and Obstet-
rics has recommended surgical staging
as the initial treatment in these patients
to determine the extent of disease. This
implies total abdominal hysterectomy
with bilateral salpingo-oophorectomy,
peritoneal cytologic samplings, and pel-
vic and paraaortic lymphadenectomy
(2). However, complete routine staging
has come under criticism in cases of low
risk of lymph node involvement (3–5).
Low-risk patients are mainly defined
with three histologic factors—tumor
type, tumor histologic grade, and myo-
metrial infiltration (3). For this reason,
many authors advocate intraoperative
gross or frozen section evaluation of
myometrial invasion and tumor grade in
clinical stage I endometrial carcinoma
to aid in the decision of whether lymph-
adenectomy should be performed or
could be obviated (6,7). Frozen section
analysis has been shown to be highly
accurate (94%) for determining myo-
metrial invasion (8). However, frozen
section analysis may be time consum-
ing, and it is not performed in all hospi-
tals. On the other hand, gross evalua-
tion has been shown to be much less
accurate (9–13) than frozen section
analysis. Therefore, a method that
could reliably assess myometrial inva-
sion preoperatively would be helpful to
provide individual tailoring of the surgi-
cal approach.
Several imaging techniques per-
formed prior to surgery are currently
used for the assessment of the depth of
myometrial infiltration by endometrial
cancer. Contrast material–enhanced
magnetic resonance (MR) imaging is
considered the most reliable method
and has an accuracy ranging from 62%
to 95% (14–20). However, MR imaging
is costly, has limited availability, and
cannot be performed in all patients.
Some groups (13,21–26) have as-
sessed the role of transvaginal two-
dimensional (2D) ultrasonography
(US) for the assessment of myometrial
invasion with considerable variation in
methods and results. This could be ex-
plained by the fact that this technique
is highly operator dependent because
it is mainly based on the subjective
impression of the examiner.
Recently, three-dimensional (3D)
US has been introduced in clinical
practice. This allows unique ways for
assessing the uterus, such as virtual
navigation through multiplanar display
and tomographic US imaging (27).
This technique has been demonstrated
to be much less operator dependent
than 2D US (28,29).
The purpose of our study was to
describe and analyze the diagnostic per-
formance of uterine virtual navigation
with 3D US for the assessment of the
depth of myometrial infiltration by en-
dometrial cancer.
Materials and Methods
Patients
Institutional review board (Clı´nica Uni-
versitaria de Navarra) approval was ob-
tained before starting the study, and all
women gave verbal informed consent.
From January 2003 to December 2007,
113 consecutive women with clinical
stage I endometrial cancer (cancer con-
fined to the uterine corpus according to
results of physical examination, chest ra-
diography, and abdominal and pelvic CT
scanning) were recruited for this pro-
spective observational study (Fig 1). Pa-
tients were from two centers—Clínica
Universitaria de Navarra, Pamplona,
Spain (n 78, 69%), and Clinic Hospital,
Barcelona, Spain (n 35, 31%).
All patients had histologically
proved endometrial cancer according
to results of office microcurettage or
hysteroscopic biopsy and were sched-
uled for surgical staging.
Exclusion criteria were as follows:
surgery not performed (n  4); surgery
performed in hospital other than that of
recruitment (n  5); incomplete patho-
logic report (n  2); and incomplete 3D
volume with exclusion of uterine serosal
margins, including one case that also did
not have a reference standard (n  6).
Three premenopausal women with child-
bearing desire with well-differentiated fo-
cal endometrioid carcinoma associated
with endometrial hyperplasia with atypia
and no signs of myometrial infiltration at
MR imaging and who were considered to
have stage IA G1 endometrioid carci-
noma were offered fertility-sparing treat-
ment. These patients did not undergo sur-
gical staging. However, we did not ex-
clude them in our analysis and considered
them to have no myometrial infiltration
for analytic purposes on the basis of MR
imaging results, in spite of the absence of
histologic data.
US Examination
All US examinations were performed
within 1 week prior to surgery, with
patients in the lithotomy position and
with an empty bladder by using a scan-
ner (Voluson 730 Expert; GE Health-
care, Milwaukee, Wis) equipped with a
multifrequency endovaginal probe (3–9
MHz). Three operators (J.L.A., R.G.,
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TDS  tumor-free distance to serosa
3D  three-dimensional
2D  two-dimensional
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Advance in Knowledge
 With uterine virtual navigation
and three-dimensional US, we
were able to predict deep myome-
trial infiltration in all cases.
Implication for Patient Care
 Three-dimensional US with uter-
ine virtual navigation offers a rela-
tively simple, reliable, and repro-
ducible way for preoperative as-
sessment of myometrial
infiltration in patients with endo-
metrial cancer.
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and S.A., with 7, 3, and 1 year of expe-
rience in 3D US, respectively) per-
formed all examinations according to a
predetermined scanning protocol (29).
A 2D US exploration of the uterus and
adnexa was initially performed. Endo-
metrial thickness was measured in the
sagittal plane, including both layers, at
the level of maximal thickness. Thereaf-
ter, the 3D volume box was activated
and was manually adjusted to include
the entire uterus. With a sweep angle of
90° and with the patient remaining as
still as possible, a 3D volume was ac-
quired. Acquisition time lasted from 6
to 10 seconds. Once the volume was
acquired, it was stored and evaluated
later with a personal computer.
Stored Volume Analysis
Two examiners (J.L.A. and S.A.) per-
formed all volume examinations in con-
sensus and were blinded to histologic re-
sults. Myometrial infiltration was as-
sessed off-line in the stored volume by
using software (4DView, version 5.0; GE
Healthcare). By using the “selected
planes” utility, we performed rotations
until uterine transverse, sagittal, and
coronal planes were placed on planes A,
B, and C, respectively, on the computer
screen (Fig 2). Virtual navigation through
the uterus then was performed. By first
going through plane B (sagittal) from the
anterior to the posterior uterine serosa,
we navigated through plane C (coronal).
By using the image with the subjective
thickest endometrial distance, we mea-
sured the myometrial TDS in the lateral
wall and fundus (Fig 3).
We then navigated in plane C (coro-
nal) from one uterine cornu to the
other. By using the image with the sub-
jective thickest endometrial distance in
plane B (sagittal), we measured TDS in
the anterior and posterior uterine walls
(Fig 4).
To determine myometrial infiltra-
tion depth, we selected the subjective
shortest TDS found in any area. Only
one measurement per area was ob-
tained.
Myometrial infiltration depth was
also estimated subjectively by the exam-
iners according to their impression of
depth of invasion (50% or 50%)
during virtual navigation. This was per-
formed by looking at the point in which
myometrial-endometrial interface was
not clearly identified and then by look-
ing at the supposedly tumor-free myo-
metrial wall at this point. By using the
opposite myometrial wall as a compari-
son, if a marked asymmetry was found,
deep (50%) infiltration was stated; if
myometrial thickness was similar in both
myometrial walls, superficial (50%) in-
filtration was stated.
Figure 1
Figure 1: Flowchart shows patient eligibility, exclusions, and results of tests on the basis of tumor-free
distance to serosa (TDS) measurement and reference standard.
Figure 2
Figure 2: Three-dimensional US images in the uterus in a case of endometrial cancer.
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Cervical involvement was stated to
be present when there was subjective
disruption of the cervical canal.
Uterine myomas were noted, and
the subjective effect of myomas on myo-
metrial measurements was assessed.
Control Subjects
To determine normal TDS in uteri with-
out pathologic examination results, we
used two control groups of asymptom-
atic women. One group included pre-
menopausal women (n  20), and the
other group included postmenopausal
women (n  20). We defined meno-
pause as 1 year of absence of menstrua-
tion in women older than 45 years.
None of these women had subjective
uterine or endometrial pathologic con-
ditions (leiomyomas, adenomyosis, con-
genital anomalies, endometrial polyps,
hyperplasia, or endometrial thickness
4 mm in postmenopausal women).
None of these women were taking hor-
monal treatments, such as contracep-
tives, hormone replacement therapy, or
tamoxifen citrate.
Reproducibility Studies
Reproducibility of TDS measurements
was assessed in the first 15 volumes.
One examiner (J.L.A.) analyzed the
same volume twice, with the second
analysis being performed at least 1
week after the first analysis. To deter-
mine interobserver reproducibility, a
second examiner (R.G.) analyzed the
same 15 volumes. Examiners were
blinded to each other’s reviews when
performing analysis. These evaluations
were performed with one examiner of
the pair different than those who evalu-
ated the volume by consensus.
Surgical Procedure and Tumor Staging
Surgery included total abdominal hysterec-
tomy with bilateral salpingo-oophorec-
tomy, peritoneal washings, omentectomy,
and pelvic and paraaortic lymphadenec-
tomy. After surgery, the pathologic report
included histologic type, histologic grade
and myometrial infiltration depth, lymph-
vascular space involvement, TDS, and
lymph node metastases. These data were
used as the reference standard. All surger-
ies were performed by gynecological on-
Figure 3
Figure 3: Three-dimensional US images (transverse, top left; sagittal, top right; coronal, bottom left) show
measurement of TDS in coronal plane (9.6 mm in right uterine wall, 14.1 mm in left uterine wall, and 15.1 in
fundus).D distance.
Figure 4
Figure 4: Three-dimensional US images (transverse, top left; sagittal, top right; coronal, bottom left) show
measurement of TDS in sagittal plane (11.2 mm in anterior uterine wall and 10.4 mm in posterior uterine wall).
D distance.
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cologists (M.J.,G.L., J.L.A., J.P., andS.M.,
eachwithmore than 10 years of experience
in gynecological oncology surgery).
Tumor stage was determined accord-
ing to International Federation of Gynecol-
ogy and Obstetrics criteria (2). Tumor his-
tologic grade was determined according to
the following three-grade system: Grade 1
carcinoma showed solid growth pattern in
less than 5% of the tumor. Grade 2 carci-
noma showed solid growth pattern in 5%–
50% of the tumor. Grade 3 carcinoma
showed solid growth pattern in more than
50% of the tumor.
Statistical Analysis
The Kolmogorov-Smirnov test was used to
assess normal distribution of continuous
data. Continuous data were compared by
using one-way analysis of variance when
data were normally distributed or by using
the Mann-Whitney U test when data were
not normally distributed. These tests were
used for comparingTDSmeasuredbyusing
US in the control groupaccording to the site
of measurement, TDS measured by using
US in the control subject and study groups,
and TDS measured by using US in study
group according to histologic depth of inva-
sion.
The Wilcoxon signed rank test was
used for comparingTDSmeasuredbyusing
US and TDS measured by a pathologist.
Categoric variables were compared by us-
ing a 2 test. The Spearman correlation co-
efficient (r) was used to assess the correla-
tion between TDS measured by using US
and TDS measured by a pathologist. A re-
ceiver operating characteristic curve was
plotted to determine the best cutoff value
for TDS for identifying deepmyometrial in-
vasion. The best cutoff value was chosen
according to the best sensitivity with the
lowest false-positive rate. Positive and neg-
ative likelihood ratios were also calculated.
Sensitivity and specificity of TDS mea-
sured by using US and those measured by
using subjective impression of infiltration
depth were compared by using the McNe-
mar test.
This was a convenience sample. Be-
cause no previous data were available for
determining a significant difference in sensi-
tivity or specificity for this technique, we
were not able to estimate a sample size
properly.
Reproducibility was assessed by us-
ing the intraclass and interclass correla-
tion coefficients according to the Bland-
Altman method (30).
A P value of .05 or less was considered
to indicate a statistically significant differ-
ence. All analyses were performed by using
software (SPSS, version 15.0; SPSS, Chi-
cago, Ill).
Results
Patient mean age was 61.8 years, rang-
ing from 31 to 86 years. Eighty-five
(89%) women were postmenopausal,
and 11 (11%) women were premeno-
pausal.
Tumor histologic features are shown
in Table 1.
Median endometrial thickness for
the study group was 13.0 mm (inter-
quartile range, 10.0; range, 1.0–49.0
mm). Median TDS at the level of fun-
dus, anterior and posterior uterine
walls, and lateral uterine wall in the
control groups are shown in Table 2.
TDS in all uterine walls was longer in
premenopausal women than in post-
menopausal women.
Median TDS measured by a pathol-
ogist and that measured by using US
were significantly shorter in those tu-
mors with 50% or more myometrial in-
filtration than in those with less than
Table 1
Histologic Features of Endometrial
Cancer
Parameter No. of Patients
Histologic type
Endometrioid 80 (83)
Adenosquamous 8 (8)
Serous papillary 6 (6)
Clear cell 2 (2)
Histologic grade
G1 42 (44)
G2 31 (32)
G3 23 (24)
Myometrial infiltration
None* 10 (10)
50% 59 (61)
50% 27 (28)
Tumor stage
IA 10 (10)
IB 48 (50)
IC 14 (15)
II 8 (8)
III 16 (17)
Note.—Data in parentheses are percentages. Percent-
ages may not add up to 100% because of rounding.
* In three cases, no myometrial infiltration was consid-
ered on the basis of MR imaging results.
Table 2
Measurement of TDS in Control Groups according to Site of Measurement
Control Group Anterior and Posterior Uterine Walls (mm)* Lateral Uterine Wall (mm)† Fundus (mm)‡
Premenopausal 17 (11–22) 15 (11–20.5) 13 (8–16)
Postmenopausal 15 (9–21) 13 (11–22) 11 (10–18)
Note.—Data are medians, with ranges in parentheses.
* P  .224, Mann-Whitney U test.
† P  .195, Mann-Whitney U test.
‡ P  .026, Mann-Whitney U test.
Table 3
TDS Measured by Using US and by a
Pathologist according to Myometrial
Infiltration
Parameter
US-Measured
TDS (mm)*
Histologically
Measured TDS
(mm)†
Myometrial
infiltration
50% 10 (2–20) 15 (6–35)
50% 4 (1–8) 4 (0–16)
Control
subjects 12 (8–22) NA
Note.—Data are medians, with ranges in parentheses.
NA  not applicable.
* P  .001 for comparison among all three groups
(myometrial infiltration  50%, myometrial infiltra-
tion  50%, and control subjects), according to the
Mann-Whitney U test.
† P  .001 for myometrial infiltration of less than 50%
versus that of 50% or more, according to the Mann-
Whitney U test.
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50% infiltration (Table 3). There was a
positive correlation between pathologi-
cally measured and US-measured TDS
(r  0.649; 95% confidence interval:
0.52, 0.76). Median TDS measured by
using US (7.0 mm; range, 1–20 mm)
was significantly shorter than that mea-
sured by a pathologist (11.0 mm; range,
0–35 mm) (P  .001) (Fig 5).
Median TDS in control groups was
significantly longer than in the study
group for tumors infiltrating less than
50% and for those infiltrating more than
50% (Table 3).
The receiver operating characteris-
tic curve showed that shorter US-mea-
sured TDS was a predictor for deep
myometrial infiltration (Fig 6). The best
cutoff value for US-measured TDS was
9.0 mm, which allowed for identification
of all cases of deep infiltration with no
false-negative cases. However, by ap-
plying this cutoff, a 39% false-positive
rate was obtained. Figure 7 shows a
case of deep myometrial infiltration as
determined by using 3D US.
One case in the control group had a
TDS of 8.0 mm.
Sensitivity, specificity, positive pre-
dictive value, negative predictive value,
and likelihood ratio for TDS and subjec-
tive impression are shown in Tables 4
and 5. With subjective impression, the
Figure 5
Figure 5: Scatterplot shows TDS measured by
using US versus that measured by a pathologist.
Figure 6
Figure 6: Receiver operating characteristic
curve for TDS. Area under the curve for TDS was
0.89 (95% confidence interval: 0.82, 0.95). Best
cutoff for TDS was 9.0 mm.
Figure 7
Figure 7: Three-dimensional US images show deep myometrial infiltration. The shortest TDS was 4.0 mm
in the fundus.D distance.
Table 4
Diagnostic Performance of Shortest
TDS Measured by Using US
Parameter
Myometrial
Infiltration
Total50% 50%
TDS
9.0 mm 42 0 42
9.0 mm 27 27 54
Total 69 27 96
Note.—Sensitivity was 100% (95% confidence interval:
87.5%, 100%). Specificity was 61% (95% confidence
interval: 48%, 71.5%). Positive predictive value was
50%. Negative predictive value was 100%. Positive
likelihood ratio was 2.56 (95% confidence interval:
1.90, 3.43).
Table 5
Diagnostic Performance of Subjective
Impression of Examiner
Parameter
Myometrial
Infiltration
Total50% 50%
Subjective
impression
50% 57 2 59
50% 12 25 37
Total 69 27 96
Sensitivity was 92.6% (95% confidence interval:
76.6%, 97.9%). Specificity was 82.6% (95% confi-
dence interval: 72.0%, 89.8%). Positive predictive value
was 67.6%. Negative predictive value was 96.6%. Pos-
itive likelihood ratio was 5.32 (95% confidence interval:
3.15, 9.00). Negative likelihood ratio was 0.09 (95%
confidence interval: 0.02, 0.34).
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false-positive rate was 17.4%, which
was much lower than that of TDS (P 
.001). However, sensitivity was also
lower at 92.6%.
Myomas were found in 26 (27%)
patients. In most of the cases, the loca-
tion was subserous. In five cases, the
presence affected the measurement of
TDS. In three of these cases, myome-
trial infiltration was overestimated be-
cause the examiner measured from the
myometrial-endometrial interface to
the inner border of the myoma, result-
ing in a TDS shorter than what it actu-
ally was.
Intraobserver and interobserver re-
producibility for US TDS measurement
were high, with intraclass correlation
coefficients of 0.967 and 0.912, respec-
tively.
Cervical involvement was correctly
identified in seven of eight (88%) cases
of stage II endometrial carcinoma.
Discussion
Myometrial infiltration is one of the most
important factors associated with lymph
node metastases (31) in endometrial car-
cinoma. In spite of International Federa-
tion of Gynecology and Obstetrics recom-
mendations about surgical staging in
endometrial cancer, the role of compre-
hensive lymphadenectomy in cases of en-
dometrioid histologic type (32,33) re-
mains controversial. The key question is
whether systematic pelvic and para-
aortic lymphadenectomy is beneficial
in all patients or could be safely obvi-
ated in selected cases. Therefore, re-
liable estimation of myometrial in-
filtration is essential for deciding
whether to perform lymph node dis-
section. Most gynecologic oncologists
rely on intraoperative gross or frozen
section pathologic analysis once the
uterus has been removed. However,
gross evaluation has a sensitivity of
67%–77%, which means a false-nega-
tive rate for detection of deep myo-
metrial invasion of about 23%–33%
(10–14).
MR imaging and transvaginal 2D US
have been proposed for preoperative
evaluation of myometrial infiltration by
endometrial cancer. In many institu-
tions, MR imaging has become a stan-
dard method. Sensitivity reported for
this technique ranges from 80% to 91%
(16–21).
Three-dimensional US allows virtual
navigation by using multiplanar display
and tomographic US imaging, which
renders images in planes similar to
those seen at MR imaging (28). This
technique has been demonstrated to be
much less operator dependent than 2D
US (29).
A study by Lindauer et al (34) dem-
onstrated that TDS has a significant
prognostic importance for predicting
recurrence in endometrial cancer. On
the basis of this study, we speculated
that we could reliably measure this dis-
tance by using 3D US and performing a
virtual navigation throughout the uterus
to identify the shortest myometrial
TDS. This should be performed in all
orthogonal planes because tumors may
infiltrate any region of the myometrium.
Assessment of the sagittal plane by
using 2D US is the traditional image
plane utilized, but the coronal plane is
frequently impossible to visualize by us-
ing 2D US. However, 3D US allows the
assessment of the uterine coronal plane
in almost all circumstances.
We found a significant positive cor-
relation between TDS measured by us-
ing US and that measured by a patholo-
gist. The presence of myomas may af-
fect the reliability of TDS measurement
because they may be a source of false-
positive cases. This could be considered
a shortcoming of this technique. How-
ever, similar problems have been found
when using MR imaging (35).
Our data show that a 9.0-mm cutoff
for TDS can accurately identify all cases
of deep infiltration with no false-nega-
tive cases. By applying this cutoff, a
39% false-positive rate was obtained.
This relatively high false-positive rate is
a shortcoming for this technique in clin-
ical practice.
Another limitation for this measure-
ment was that healthy women may have
TDS less than 9.0 mm.
With subjective impression, the
false-positive rate was 17.4%, which is
much lower; however, sensitivity de-
creased to 92.6%. Therefore, it could
be argued that subjective impression
has a better performance than 3D US.
However, because it is important to
perform surgery only once, false-posi-
tive cases are less relevant than false-
negative cases from the point of view of
the oncologist. Therefore, we believe
that this technique could be helpful in
those cases in which MR imaging is not
available or cannot be performed.
In summary, we have shown that
virtual navigation with 3D US is repro-
ducible and helps identify all cases of
deep myometrial infiltration. However,
future larger prospective studies are
needed to define its actual role in clini-
cal practice.
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